Corporate Advisory

PharmaDeals v4

PharmaTelevision

Industry Insight and Intelligence

 

PTV Latest

Cancer Research Technology: Keith Blundy on Collaborating with Big Pharma

More
A Jigsaw of the World

Register for E-Mail Updates

Email Address
Submit

About PharmaDeals Reports

PharmaVentures recognises the needs of Business Executives negotiating multi-million dollar deals. By drawing on both our industry knowledge and our experience of writing reports, we can provide the level of intelligence today’s healthcare professionals need. PharmaDeals® Reports contain insights based on over 17 years of experience in assisting pharmaceutical and biotechnology companies worldwide.

PhamaDeals Reports will help you with

  • Creating robust licensing agreements
  • Maximising the value of your deals
  • Calculating royalty rates
  • Enhancing your deal making abilities

Specific reports may help you achieve many more defined objectives; these are just some generic examples of how the reports may help your business strategy.

Key Benefits

  • PharmaDeals Reports are written by a team of industry experts so you can rest assured you are accessing current and accurate opinion
  • PharmaDeals Reports are carefully researched to include topics and issues that are of vital importance to deal makers
  • Professionally edited and published so you can access the information you need quickly and efficiently
  • Key report titles are supported by participative PharmaDeals Academy workshops in order to maximise your understanding of the topic
PharmaDeals Reports Logo

New Report

The Royalty Rate Report 2012: A Comprehensive Assessment of Valuation in the Pharmaceutical Sector

This Report is the pharmaceutical and biotech industry’s standard reference work on royalty rates, published annually by PharmaVentures, the experts in deals and alliances, now online and fully interactive. The 2012 Report presents major new case studies, and provides full, new data and analysis based on data from the premier agreements database, PharmaDeals v4, and other sources. Topics include Royalties and Deal Structures, Sales Milestones, Tiered Royalties, Alternative Structures, Technology Deals, Deal Creativity, Upfront Payments and Milestones, Royalties and IP Values and Market Cap, and Royalty Rates by Phase and Indication.